Sequoia Financial Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1599900
Akron, OH
Position in REGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,675,451
-$788,497 QoQ
Shares Held
2,687
-15.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#551
of 1,322 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $32,926,453 across 49 Biotechnology names. REGN ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,729 | $8,309,796 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
175,864 | $3,060,033 | |
| 3 | INCY |
Incyte Corp
|
19,250 | $2,182,180 | |
| 4 | ARGX |
Argenx SE
|
2,045 | $1,897,289 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,687 | $1,675,451 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,347 | $1,308,577 | |
| 7 | EXEL |
Exelixis, Inc.
|
20,292 | $1,104,087 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
4,527 | $1,090,871 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,675,451 | 2,687 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,463,948 | 3,189 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,276,244 | 2,949 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,492,264 | 2,654 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $924,525 | 1,761 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,024,281 | 1,615 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,245,865 | 1,749 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $1,829,157 | 1,740 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,599,667 | 1,522 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,394,648 | 1,449 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,843,530 | 2,099 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $986,729 | 1,199 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $862,248 | 1,200 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,007,367 | 1,226 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $759,007 | 1,052 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $264,526 | 384 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $282,560 | 478 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $345,717 | 495 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $253,871 | 402 | Shares | Sole | 2022-02-22 | |
| 2020-12-31 | $202,906 | 420 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $255,819 | 457 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $347,373 | 557 | Shares | Sole | 2020-08-25 | |
| 2020-03-31 | $253,422 | 519 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||